SCHEMBL24675798

SCHEMBL24675798

COC(=O)COCCCOCCCCCOc1cccc([C@@H](C)N)c1

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
LMNA P02545 1/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYSLTR2 Q9NS75 3/20 0.42
CYSLTR1 Q9Y271 3/20 0.42
HRH3 Q9Y5N1 1/20 0.41
CACNA1B Q00975 1/20 0.40
SMPD1 P17405 3/20 0.39
NSD2 O96028 1/20 0.39
PTGES O14684 1/20 0.39
ALOX5 P09917 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24675471 1.00 KDM4E (0.45) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675470 1.00 KDM4E (0.45) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675854 0.98 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675859 0.98 KDM4E (0.46) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675595 0.88 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675246 0.88 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL25828664 0.88 ALDH1A1 (0.45) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675494 0.88 SMN1; SMN2 (0.45) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675778 0.88 SMN1; SMN2 (0.45) KDM4EALDH1A1SMN1; SMN2LMNAMEN1
SCHEMBL24675467 0.88 SMN1; SMN2 (0.49) KDM4EALDH1A1SMN1; SMN2LMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023129564-A9 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2024-02-08 WO disclosed
WO-2022159688-A9 DEGRADERS OF GRK2 AND USES THEREOF SONATA THERAPEUTICS, INC. (US) 2023-09-21 WO disclosed
WO-2023129564-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2023-07-06 WO disclosed
WO-2022159688-A1 DEGRADERS OF GRK2 AND USES THEREOF CYGNAL THERAPEUTICS, INC. (US) 2022-07-28 WO disclosed